CMT episode 1: Challenges in the diagnosis and treatment of inherited neuropathies
2026 ENMC Workshops: Optimizing collaborative models in neuromuscular diseases: the role of ontologies and artificial intelligence (THEMED WORKSHOP #291)
CMT Episode 2: Progress in Genetic Diagnosis for Neuropathies
Knowledge Sharing Sessions – Feasibility of a Home-Based Exergaming Intervention for Youth With Spinal Muscular Atrophy.
Knowledge Exchange Sessions – Contracture Management: A Practical Take
CPD-Accredited Webinar | Canadian Guidelines for the Management of Spinal Bulbar Muscular Atrophy
NMD4C and Muscular Dystrophy Canada are pleased to invite you to a CPD-accredited webinar on the Canadian Guidelines for the Management of Spinal Bulbar Muscular Atrophy. This CPD Accredited webinar primarily targeted at Canadian clinicians, academics and trainees with an interest in neuromuscular diseases.
Speakers:
- Dr. Kerri Schellenberg (chair)
- Dr. Gerald Pfeffer
Details:
- Date: Tuesday Feb 3rd, 2026
- Time: 5-6 pm ET
Learning objectives:
- Discuss the need for the recently published Canadian guidelines
- Recognize the significance of Spinal Bulbar Muscular Atrophy for Indigenous people in Canada
- Understand what the new SBMA Guidelines mean for health care professionals
- Discuss ongoing endeavors to promote awareness of SBMA guidelines.
The NMD Rounds & Educational Webinars are self-approved group learning activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada. NMD4C and MDC are providing organizational and technical support. This webinar is supported by Novartis through a restricted educational sponsorship with no involvement or influence on program content.
If you have any questions, please contact our Network Manger, Erin Beattie